Abstract:Anti-tumor M1-like and pro-tumor M2-like tumor-associated macrophages (TAMs) coexist in tumor microenvironments (TME). The adverse effects of these M1/M2 subsets on tumors directly affect the current strategies to improve anti-tumor immune response. Therefore, it has attracted great attention to change the tumor immunosuppressive microenvironment by reprogramming TAMs. In this paper, we constructed biomimetic nanoparticles (HMMDN-Met@PM) targeting M2-like TAMs for macrophage re-polarization. In detail, the core of the biomimetic nanoparticles is metformin-loaded hollow mesoporous manganese dioxide nanoparticles (HMMDN-Met). Benefited from the hollow and porous structure of HMMDN, metformin, the regulator of M1/M2 adopted in this work, can be easily and widely loaded into HMMDN. Moreover, macrophage membranes were utilized for HMMDN-Met coating (HMMDN-Met@MM) to prevent the premature drug leakage and provide specific molecular recognition/TME targeting. In addition, M2 macrophage targeting peptide (M2pep) was modified on the surface of macrophage membrane to specifically deliver the drug to M2-like TAMs to promote the polarization of M2 to M1 macrophages. Through in vitro and in vivo studies, we found that the expression of surface markers and inflammatory factors CD206, Arg-1 and IL-10 of type M2 macrophages decreased, while the surface markers of type M1 macrophages and the expression of inflammatory factors CD80, TNF-α and iNOS increased, indicating the successful re-polarization of M2 macrophages and finally realizing the inhibition of tumor growth. At the same time, under the acidic and GSH conditions of tumor, HMMDN was decomposed into Mn 2+ , which is a contrast agent for magnetic resonance imaging, thus realizing the tracking of tumor. This work practices biomimetic nanosystem in targeted imaging and immunotherapy, paving the way for strategy designing for tumor inhibition.

How to use macrophages to realise the treatment of tumour

The promising role of tumor-associated macrophages in the treatment of cancer

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Role of macrophage in nanomedicine-based disease treatment

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Targeting Tumor-Associated Macrophages As an Antitumor Strategy.

Use of macrophage as a Trojan horse for cancer nanotheranostics

Anti-tumour strategies aiming to target tumour-associated macrophages.

Macrophage-modulating nanomedicine for cancer immunotherapy

Engineering macrophages and their derivatives: A new hope for antitumor therapy

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles

Targeting tumor-associated macrophages to synergize tumor immunotherapy

The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis

Engineering Macrophages <i>via</i> Nanotechnology and Genetic Manipulation for Cancer Therapy

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Research Progress on the Role of Tumor‑associated Macrophages in Tumor Development and Their Use As Molecular Targets (Review).

Targeting tumor-associated macrophages for cancer treatment